BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...

Blood management systems provider Haemonetics Corp. of Braintree today announced acquisition of Engineering and Research Associates Inc.’s blood collection and processing business for $12.5 ...

Haemonetics Corp. has announced it has completed the acquisition of the business assets of Pall Corp.’s blood collection, filtration and processing product lines, according to a news release. The ...

Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...

Haemonetics’ fourth quarter results were met with a negative market reaction, reflecting investor caution despite the company’s performance exceeding Wall Street’s revenue and earnings expectations.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient ...

The largest contributor was Haemonetics Corp., a medical device company focused on products related to blood collection and management.